Breakdown | ||
Income Statement | Total Revenue | |
Gross Profit | ||
EBIT | ||
EBITDA | ||
Net Income Common Stockholders | ||
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |
Total Assets | ||
Total Debt | ||
Net Debt | ||
Total Liabilities | ||
Stockholders Equity | ||
Cash Flow | Free Cash Flow | |
Operating Cash Flow | ||
Investing Cash Flow | ||
Financing Cash Flow | ||
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | £295.42M | 7.46 | 13.74% | 8.06% | 6.77% | 32.64% | |
75 Outperform | £9.92M | 4.43 | 2.04% | ― | 6.94% | ― | |
69 Neutral | £71.27M | 16.63 | 11.76% | 2.62% | 23.22% | 81.79% | |
65 Neutral | $8.81B | 14.92 | 4.67% | 6.17% | 3.60% | -2.89% | |
44 Neutral | £395.06K | ― | -46.96% | ― | 10.90% | ― |